Skip to main content
. Author manuscript; available in PMC: 2019 Jul 16.
Published in final edited form as: Lancet. 2015 Feb 27;385(9982):2077–2087. doi: 10.1016/S0140-6736(14)61685-8

Figure 4. Secondary endpoints.

Figure 4

Figure shows INR correction and factor-level repletion in the ITT-E population. Data are proportion of patients or mean percentage of normal levels (SD). 4F-PCC=four-factor prothrombin complex concentrate. INR=international normalised ratio. ITT-E=intention-to-treat efficacy.